Trial Profile
A randomized, open label, cross-over study comparing effectiveness for the montelukast sodium with comparator in mild to moderate persistent asthmatics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Theophylline
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 01 Feb 2007 Status changed from in progress.
- 31 Dec 2005 New trial record.